Captor Therapeutics ® Investor Relations

      Investor Relations

      Notice of reduction of shareholding interest in the Company

      Publication date: 2021-05-28
      Number: RB ESPI 9/2021

      Current report no. 9/2021

      Date of preparation: 28 May 2021

      Subject: Notice of reduction of shareholding interest in the Company

      Legal basis: Article 70 point 1) of the Act on Public Offering and Conditions Governing the Introduction of Financial Instruments to Organized Trading System and of Public Companies dated 29 July 2005

      The Management Board of Captor Therapeutics S.A. with its registered office in Wrocław (the “Company”) informs that it received from Michał Walczak a notice of reduction of his shareholding to 27.61% of the total number of votes in the Company, drawn up pursuant to Article 69 sec. 1 point 2) and sec. 2 point 1) of the Act on Public Offering and Conditions Governing the Introduction of Financial Instruments to Organized Trading System and of Public Companies dated 29 July 2005. The notice constitutes an appendix to this report.


      Attachments: